Danaher (NYSE:DHR) Earns Buy Rating from Analysts at Guggenheim

Guggenheim started coverage on shares of Danaher (NYSE:DHR) in a research report report published on Thursday, Marketbeat.com reports. The brokerage issued a buy rating and a $275.00 price objective on the conglomerate’s stock.

DHR has been the topic of a number of other research reports. Stephens restated an “overweight” rating and set a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Raymond James decreased their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. KeyCorp increased their price objective on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research report on Thursday, October 31st. Finally, Barclays dropped their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $287.30.

Danaher Trading Down 0.9 %

Shares of DHR stock opened at $226.16 on Thursday. Danaher has a 1 year low of $222.53 and a 1 year high of $281.70. The firm has a fifty day moving average price of $243.90 and a 200-day moving average price of $256.72. The company has a market cap of $163.35 billion, a price-to-earnings ratio of 43.16, a PEG ratio of 4.33 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.02 earnings per share. As a group, equities analysts predict that Danaher will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.48%. The ex-dividend date is Friday, December 27th. Danaher’s payout ratio is 20.61%.

Institutional Investors Weigh In On Danaher

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC increased its position in shares of Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares in the last quarter. Legal & General Group Plc grew its stake in Danaher by 2.4% during the 2nd quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate’s stock worth $1,490,112,000 after buying an additional 139,989 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Danaher by 3.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock valued at $1,417,342,000 after buying an additional 148,251 shares during the last quarter. Fisher Asset Management LLC boosted its holdings in Danaher by 2.6% in the third quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock worth $1,265,725,000 after acquiring an additional 116,299 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its stake in shares of Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after acquiring an additional 535,254 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.